Search research articles
Contact Us
Filters
Showing results (441-450 of 490) with videos related to
Page
of 49
Sort By:
Anticancer Research
|
June 3, 2006
Calcitonin measurements for early detection of medullary thyroid carcinoma or its premalignant conditions in Hashimoto's thyroiditis
Matthias Schuetz, Mohsen Beheshti, Semun Oezer, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 6, 2004
Cytotoxic activity of camptothecin and paclitaxel in newly established continuous human medullary thyroid carcinoma cell lines
K Kaczirek, M Schindl, A Weinhäusel, et al.
Annals of Hematology
|
March 1, 1995
The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML--a comparative morphometric study on sequential trephine biopsies
J Thiele, H M Kvasnicka, N Niederle, et al.
The New England Journal of Medicine
|
October 27, 1994
Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors
I Virgolini, M Raderer, A Kurtaran, et al.
Hematopathology and Molecular Hematology
|
January 1, 1996
Effects of interferon treatment on the macrophage population in the bone marrow of patients with Ph1+-CML
J Thiele, H M Kvasnicka, T K Zirbes, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 26, 2008
Low telomerase activity: possible role in the progression of human medullary thyroid carcinoma
Guido Stadler, Matthias Wieser, Berthold Streubel, et al.
Anticancer Research
|
June 17, 2009
Establishment and characterization of three novel cell lines - P-STS, L-STS, H-STS - derived from a human metastatic midgut carcinoid
Roswitha Pfragner, Annemarie Behmel, Harald Höger, et al.
Nuklearmedizin. Nuclear Medicine
|
November 26, 2014
[Treatment of patients with radioiodine refractory, differentiated thyroid carcinoma. A Consensus Statement]
Christina Lindner, J Dierneder, G Pall, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 13, 2002
Stimulation of autologous antitumor T-cell responses against medullary thyroid carcinoma using tumor lysate-pulsed dendritic cells
T Bachleitner-Hofmann, A Stift, J Friedl, et al.
Oncology Reports
|
May 9, 2009
Pilot trial of autologous dendritic cells loaded with tumor lysate(s) from allogeneic tumor cell lines in patients with metastatic medullary thyroid carcinoma
Thomas Bachleitner-Hofmann, Josef Friedl, Michaela Hassler, et al.
Page
of 49
Search research articles
Search
Showing results (441-450 of 490) with videos related to
Sort By:
Page
of 49
Anticancer Research
|
June 3, 2006
Calcitonin measurements for early detection of medullary thyroid carcinoma or its premalignant conditions in Hashimoto's thyroiditis
Matthias Schuetz, Mohsen Beheshti, Semun Oezer, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 6, 2004
Cytotoxic activity of camptothecin and paclitaxel in newly established continuous human medullary thyroid carcinoma cell lines
K Kaczirek, M Schindl, A Weinhäusel, et al.
Annals of Hematology
|
March 1, 1995
The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML--a comparative morphometric study on sequential trephine biopsies
J Thiele, H M Kvasnicka, N Niederle, et al.
The New England Journal of Medicine
|
October 27, 1994
Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors
I Virgolini, M Raderer, A Kurtaran, et al.
Hematopathology and Molecular Hematology
|
January 1, 1996
Effects of interferon treatment on the macrophage population in the bone marrow of patients with Ph1+-CML
J Thiele, H M Kvasnicka, T K Zirbes, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 26, 2008
Low telomerase activity: possible role in the progression of human medullary thyroid carcinoma
Guido Stadler, Matthias Wieser, Berthold Streubel, et al.
Anticancer Research
|
June 17, 2009
Establishment and characterization of three novel cell lines - P-STS, L-STS, H-STS - derived from a human metastatic midgut carcinoid
Roswitha Pfragner, Annemarie Behmel, Harald Höger, et al.
Nuklearmedizin. Nuclear Medicine
|
November 26, 2014
[Treatment of patients with radioiodine refractory, differentiated thyroid carcinoma. A Consensus Statement]
Christina Lindner, J Dierneder, G Pall, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 13, 2002
Stimulation of autologous antitumor T-cell responses against medullary thyroid carcinoma using tumor lysate-pulsed dendritic cells
T Bachleitner-Hofmann, A Stift, J Friedl, et al.
Oncology Reports
|
May 9, 2009
Pilot trial of autologous dendritic cells loaded with tumor lysate(s) from allogeneic tumor cell lines in patients with metastatic medullary thyroid carcinoma
Thomas Bachleitner-Hofmann, Josef Friedl, Michaela Hassler, et al.
Page
of 49